Related Experiment Video
Updated: Jul 31, 2026
08:00
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
Systemic steroids for the management of obstructive subglottic hemangioma
1Department of Otolaryngology, Montreal Children's Hospital, McGill University, Quebec.
The Journal of Otolaryngology
|January 5, 2002
Summary
Systemic steroids effectively treat paediatric subglottic hemangioma, a common cause of airway obstruction. This approach offers a safe alternative for managing these challenging cases in children.
Area of Science:
- Pediatric Otolaryngology
- Vascular Anomalies
- Respiratory Medicine
Background:
- Subglottic hemangioma is a significant cause of upper airway obstruction in children.
- These lesions can lead to severe breathing difficulties, necessitating effective treatment strategies.
Purpose of the Study:
- To evaluate the safety and efficacy of systemic steroids in managing obstructive pediatric subglottic hemangiomas.
- To present treatment outcomes for patients with subglottic hemangioma.
Main Methods:
- Retrospective review of 14 pediatric patients treated between 1984 and 1997.
- Treatment involved systemic steroids for lesions causing >25% laryngeal obstruction or obstructive symptoms.
- Clinical, radiographic, and bronchoscopic follow-up was conducted.
Main Results:
- Nine out of ten patients (90%) responded clinically to systemic steroid therapy.
- No major complications were observed; one patient experienced reversible cushingoid features.
- Associated extralaryngeal hemangiomas were present in 28% of patients.
Conclusions:
- Systemic steroids, potentially combined with short-term intubation, represent a safe and effective treatment for obstructive pediatric subglottic hemangiomas.
- This therapeutic approach can avoid more invasive interventions.
Related Concept Videos
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:26Esophageal Strictures-II: Clinical Features and Management
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:30Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway interventions are...